Fund Holdings — Foresite Capital Management V, LLC

Total Portfolio Value
$73.39M
Total Bought
$10.85M
Total Sold
$11.77M
Net Transaction
-$920.9K
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Hims & Hers Health, Inc.(HIMS)3,733,3813,833,381+100,00023,48334,11746.49%+10,634
Theseus Pharmaceuticals, Inc.4,108,7964,108,796011,05316,64122.67%+5,588
Kinnate Biopharma Inc.3,525,9573,525,95704,9368,35711.39%+3,420
Disc Medicine, Inc.(IRON)243,513243,513011,44014,06519.16%+2,625
23andMe Holding Co.0232,200+232,20002120.29%+212
Pharvaris N.V.
COM
33,1420-33,1426920—-692
Compass Therapeutics, Inc.(CMPX)1,246,9770-1,246,9772,4570—-2,457
Aclaris Therapeutics, Inc.(ACRS)1,258,2430-1,258,2438,6190—-8,619
Page 1 of 1
Foresite Capital Management V, LLC — 13F Holdings — Q4 2023 | TickerTrail